APOF and APOA1

  • Number of citations of the paper that reports this interaction (PMID 6816269)
  • 4
  • Data Source:
  • HPRD (in vitro)

APOF

APOA1

Gene Name apolipoprotein F apolipoprotein A-I
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 2 interactors: APOA1 APOA2 35 interactors: ABCA1 ABCA13 AKT2 APOA1BP APOA2 APOB APOC1 APOF APOL1 APP ATP5B CETP CFHR1 CLEC4G CMTM5 FBLN1 GPLD1 HPR JAK3 LBP LCAT MAP7D1 MAPK6 PCMT1 PDE1A PLTP PON1 SAA2 SCARB1 SPP1 TNFRSF10C TOMM20 TTR VKORC1 ZNRD1
Entrez ID 319 335
HPRD ID 00137 02517
Ensembl ID ENSG00000175336 ENSG00000118137
Uniprot IDs Q13790 P02647
PDB IDs 1AV1 1GW3 1GW4 1ODP 1ODQ 1ODR 2A01 3J00 3K2S 3R2P
Enriched GO Terms of Interacting Partners?
Tagcloud ?
a4  antitrypsin  apoa  apoc  apod  apoh  apoj  apol  apolipoproteins  apom  atherogenic  carry  chd  convincingly  delipidation  dense  differs  fibrinogen  ldl  lysosome  originate  paraoxonase  prenylcysteine  proteome  sdldl  strengthens  subfractions  transthyretin  vldl 
admission  atherosclerosis  believed  concentration  consequence  controls  explain  explanation  explicable  fifth  genotypes  hdl  immediately  infarction  mi  microg  min  ml  myocardial  nmol  occured  paraoxonase  pon1  reside  risen  subfraction  subgroups  thrombolytic  variation 
Tagcloud (Difference) ?
a4  antitrypsin  apoa  apoc  apod  apoh  apoj  apol  apolipoproteins  apom  atherogenic  carry  chd  convincingly  delipidation  dense  differs  fibrinogen  ldl  lysosome  originate  prenylcysteine  proteome  sdldl  strengthens  subfractions  transthyretin  vldl 
admission  atherosclerosis  believed  concentration  consequence  controls  explain  explanation  explicable  fifth  genotypes  hdl  immediately  infarction  mi  microg  min  ml  myocardial  nmol  occured  pon1  reside  risen  subfraction  subgroups  thrombolytic  variation 
Tagcloud (Intersection) ?
paraoxonase